Matches in Nanopublications for { ?s ?p "[Since anti-PLGF was recently applied in clinical trials to inhibit cancer-related angiogenesis, here our data further demonstrate that inhibition of cancer neovascularization by anti-PLGF is mediated not only by direct effect on endothelial growth and capillary permeability, but also by indirect effect via MMP3 on the extracellular matrix degradation in larynx carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- NP616971.RAeO7PZOSN98ousghGkx26FJcLVIY8BLlaau5CHvkYObY130_assertion description "[Since anti-PLGF was recently applied in clinical trials to inhibit cancer-related angiogenesis, here our data further demonstrate that inhibition of cancer neovascularization by anti-PLGF is mediated not only by direct effect on endothelial growth and capillary permeability, but also by indirect effect via MMP3 on the extracellular matrix degradation in larynx carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP616971.RAeO7PZOSN98ousghGkx26FJcLVIY8BLlaau5CHvkYObY130_provenance.
- NP617072.RAblkLaefgjouUmbvBtoC_BRjTtX9A9EzPtRHnXX0WB0k130_assertion description "[Since anti-PLGF was recently applied in clinical trials to inhibit cancer-related angiogenesis, here our data further demonstrate that inhibition of cancer neovascularization by anti-PLGF is mediated not only by direct effect on endothelial growth and capillary permeability, but also by indirect effect via MMP3 on the extracellular matrix degradation in larynx carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP617072.RAblkLaefgjouUmbvBtoC_BRjTtX9A9EzPtRHnXX0WB0k130_provenance.
- NP617103.RASRkMr-15lbxfKqrpXNMfnvWdKlLeJzo5uno4Vg53c-0130_assertion description "[Since anti-PLGF was recently applied in clinical trials to inhibit cancer-related angiogenesis, here our data further demonstrate that inhibition of cancer neovascularization by anti-PLGF is mediated not only by direct effect on endothelial growth and capillary permeability, but also by indirect effect via MMP3 on the extracellular matrix degradation in larynx carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP617103.RASRkMr-15lbxfKqrpXNMfnvWdKlLeJzo5uno4Vg53c-0130_provenance.
- NP1193821.RAHtDrbDtWKbkpjQOgf8aYbNTaVeR1n9hEVFUMSjmN2to130_assertion description "[Since anti-PLGF was recently applied in clinical trials to inhibit cancer-related angiogenesis, here our data further demonstrate that inhibition of cancer neovascularization by anti-PLGF is mediated not only by direct effect on endothelial growth and capillary permeability, but also by indirect effect via MMP3 on the extracellular matrix degradation in larynx carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1193821.RAHtDrbDtWKbkpjQOgf8aYbNTaVeR1n9hEVFUMSjmN2to130_provenance.